ATE187175T1 - Adenosinkinaseinhibitoren - Google Patents
AdenosinkinaseinhibitorenInfo
- Publication number
- ATE187175T1 ATE187175T1 AT92300580T AT92300580T ATE187175T1 AT E187175 T1 ATE187175 T1 AT E187175T1 AT 92300580 T AT92300580 T AT 92300580T AT 92300580 T AT92300580 T AT 92300580T AT E187175 T1 ATE187175 T1 AT E187175T1
- Authority
- AT
- Austria
- Prior art keywords
- kinase inhibitors
- adenosin
- adenosine
- methods
- adenosine kinase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64711791A | 1991-01-23 | 1991-01-23 | |
US81291691A | 1991-12-23 | 1991-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE187175T1 true ATE187175T1 (de) | 1999-12-15 |
Family
ID=27095094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92300580T ATE187175T1 (de) | 1991-01-23 | 1992-01-23 | Adenosinkinaseinhibitoren |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0496617B1 (de) |
JP (1) | JPH05112595A (de) |
AT (1) | ATE187175T1 (de) |
CA (1) | CA2100863A1 (de) |
DE (1) | DE69230347T2 (de) |
FI (1) | FI933303A (de) |
IL (1) | IL100742A (de) |
MX (1) | MX9200294A (de) |
NO (1) | NO180418C (de) |
NZ (1) | NZ241381A (de) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5763596A (en) * | 1989-09-15 | 1998-06-09 | Metabasis Therapeutics, Inc. | C-4' modified adenosine kinase inhibitors |
US5674998A (en) * | 1989-09-15 | 1997-10-07 | Gensia Inc. | C-4' modified adenosine kinase inhibitors |
US5763597A (en) * | 1989-09-15 | 1998-06-09 | Metabasis Therapeutics, Inc. | Orally active adenosine kinase inhibitors |
US5721356A (en) * | 1989-09-15 | 1998-02-24 | Gensia, Inc. | Orally active adenosine kinase inhibitors |
US5864033A (en) * | 1989-09-15 | 1999-01-26 | Metabasis Therapeutics, Inc. | Adenosine kinase inhibitors |
US5726302A (en) * | 1989-09-15 | 1998-03-10 | Gensia Inc. | Water soluble adenosine kinase inhibitors |
US5795977A (en) * | 1989-09-15 | 1998-08-18 | Metabasis Therapeutics, Inc. | Water soluble adenosine kinase inhibitors |
US5506347A (en) * | 1993-02-03 | 1996-04-09 | Gensia, Inc. | Lyxofuranosyl analogues of adenosine |
TW370529B (en) | 1992-12-17 | 1999-09-21 | Pfizer | Pyrazolopyrimidines |
EP0729758A3 (de) * | 1995-03-02 | 1997-10-29 | Pfizer | Pyrazolopyrimidine und Pyrrolopyrimidine zur Behandlung von neuronalen und anderen Krankheiten |
US6143749A (en) * | 1995-06-07 | 2000-11-07 | Abbott Laboratories | Heterocyclic substituted cyclopentane compounds |
US5665721A (en) * | 1995-06-07 | 1997-09-09 | Abbott Laboratories | Heterocyclic substituted cyclopentane compounds |
ATE227734T1 (de) * | 1995-08-18 | 2002-11-15 | Univ Michigan | 5'-substitutierte-ribofuranosyl benzimidazolen als antivirale. |
US6051578A (en) * | 1996-02-12 | 2000-04-18 | Pfizer Inc. | Pyrazolopyrimidines for treatment of CNS disorders |
GB9604361D0 (en) * | 1996-02-29 | 1996-05-01 | Pharmacia Spa | 4-Substituted pyrrolopyrimidine compounds as tyrosine kinase inhibitors |
NZ331804A (en) * | 1996-03-15 | 2000-04-28 | Novartis Ag | N-7-heterocyclyl pyrrolo[2,3-d]pyridines and their use |
US6107300A (en) * | 1996-03-27 | 2000-08-22 | Dupont Pharmaceuticals | Arylamino fused pyrimidines |
WO1998014449A1 (en) * | 1996-10-02 | 1998-04-09 | Novartis Ag | Fused pyrazole derivatives and processes for their preparation |
US7863444B2 (en) | 1997-03-19 | 2011-01-04 | Abbott Laboratories | 4-aminopyrrolopyrimidines as kinase inhibitors |
US6713474B2 (en) | 1998-09-18 | 2004-03-30 | Abbott Gmbh & Co. Kg | Pyrrolopyrimidines as therapeutic agents |
NZ510588A (en) * | 1998-09-18 | 2003-08-29 | Abbott Gmbh & Co | Pyrrolopyrimidines as protein kinase inhibitors |
US7071199B1 (en) | 1999-09-17 | 2006-07-04 | Abbott Gmbh & Cco. Kg | Kinase inhibitors as therapeutic agents |
CZ2002936A3 (cs) | 1999-09-17 | 2002-10-16 | Abbott Gmbh & Co. Kg | Pyrazolopyrimidiny jako terapeutické prostředky |
WO2001072751A1 (en) * | 2000-03-29 | 2001-10-04 | Knoll Gesellschaft Mit Beschraenkter Haftung | Pyrrolopyrimidines as tyrosine kinase inhibitors |
GB0100622D0 (en) | 2001-01-10 | 2001-02-21 | Vernalis Res Ltd | Chemical compounds V111 |
DE10238724A1 (de) | 2002-08-23 | 2004-03-04 | Bayer Ag | Alkyl-substituierte Pyrazolpyrimidine |
DE10238723A1 (de) | 2002-08-23 | 2004-03-11 | Bayer Ag | Phenyl-substituierte Pyrazolyprimidine |
DE10238722A1 (de) | 2002-08-23 | 2004-03-11 | Bayer Ag | Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse |
US7834014B2 (en) | 2003-04-09 | 2010-11-16 | Biogen Idec Ma Inc. | A2a adenosine receptor antagonists |
US7674791B2 (en) | 2003-04-09 | 2010-03-09 | Biogen Idec Ma Inc. | Triazolopyrazines and methods of making and using the same |
EP1615930A2 (de) | 2003-04-09 | 2006-01-18 | Biogen Idec MA, Inc. | Als a2a-adenosinrezeptor-antagonisten geeignete triazolotriazine und pyrazolotriazine |
DE10320785A1 (de) | 2003-05-09 | 2004-11-25 | Bayer Healthcare Ag | 6-Arylmethyl-substituierte Pyrazolopyrimidine |
US8044060B2 (en) | 2003-05-09 | 2011-10-25 | Boehringer Ingelheim International Gmbh | 6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory |
DE102004001873A1 (de) | 2004-01-14 | 2005-09-29 | Bayer Healthcare Ag | Cyanopyrimidinone |
PE20060272A1 (es) | 2004-05-24 | 2006-05-22 | Glaxo Group Ltd | (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a |
WO2006068760A2 (en) | 2004-11-19 | 2006-06-29 | The Regents Of The University Of California | Anti-inflammatory pyrazolopyrimidines |
EP1746099A1 (de) * | 2004-12-23 | 2007-01-24 | DeveloGen Aktiengesellschaft | Mnk1 or Mnk2 Inhibitoren |
GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
DE102006029074A1 (de) | 2006-06-22 | 2007-12-27 | Friedrich-Schiller-Universität Jena | 4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe |
TW200827367A (en) * | 2006-10-26 | 2008-07-01 | Kyowa Hakko Kogyo Kk | A therapeutic agent for irritable bowel syndrome |
JP5498392B2 (ja) | 2007-11-30 | 2014-05-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 1,5−ジヒドロ−ピラゾロ[3,4−d]ピリミジン−4−オン誘導体及びcns障害の治療のためのpde9aモジュレーターとしてのそれらの使用 |
UA105362C2 (en) | 2008-04-02 | 2014-05-12 | Бьорингер Ингельхайм Интернациональ Гмбх | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
WO2009140588A1 (en) * | 2008-05-15 | 2009-11-19 | Trustees Of Tufts College | Silk polymer-based adenosine release: therapeutic potential for epilepsy |
WO2010006072A2 (en) | 2008-07-08 | 2010-01-14 | The Regents Of The University Of California | Mtor modulators and uses thereof |
WO2010026214A1 (en) | 2008-09-08 | 2010-03-11 | Boehringer Ingelheim International Gmbh | Pyrazolopyrimidines and their use for the treatment of cns disorders |
PL2414363T3 (pl) | 2009-03-31 | 2014-06-30 | Boehringer Ingelheim Int | Pochodne 1-heterocyklilo-1,5-dihydro-pirazolo[3,4-d]pirymidyn-4-onu i ich zastosowanie jako modulatorów PDE9A |
EP2264234A1 (de) | 2009-06-16 | 2010-12-22 | Amann & Söhne GmbH & Co. KG | Garn, insbesondere Näh- oder Stickgarn |
UA110347C2 (uk) | 2010-08-12 | 2015-12-25 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | ПОХІДНІ 6-ЦИКЛОАЛКІЛ-1,5-ДИГІДРОПІРАЗОЛО[3,4-d]ПІРИМІДИН-4-ОНУ І ЇХ ЗАСТОСУВАННЯ ЯК ІНГІБІТОРІВ PDE9A |
US8809345B2 (en) | 2011-02-15 | 2014-08-19 | Boehringer Ingelheim International Gmbh | 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders |
EP2766367B1 (de) | 2011-10-14 | 2022-05-18 | Scandion Oncology A/S | 4-Amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidin-Derivate zur Behandlung von viralen Infekten, insbesondere von Picornavirusinfektionen |
DE102012004736A1 (de) | 2011-10-20 | 2013-04-25 | Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg | 4-Amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidin-Derivate und deren Verwendung als antivirale Wirkstoffe |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3962211A (en) * | 1975-01-13 | 1976-06-08 | The University Of Utah | 7-substituted nucleoside compounds |
US4455420A (en) | 1983-01-13 | 1984-06-19 | Hoffmann-La Roche Inc. | 4-Amino-7-(5-deoxy-beta-D-ribofuranosyl)-5-iodo-7H-pyrrolo[2,3-d] pyrimidine |
-
1992
- 1992-01-21 CA CA002100863A patent/CA2100863A1/en not_active Abandoned
- 1992-01-23 IL IL10074292A patent/IL100742A/en not_active IP Right Cessation
- 1992-01-23 AT AT92300580T patent/ATE187175T1/de active
- 1992-01-23 DE DE69230347T patent/DE69230347T2/de not_active Expired - Fee Related
- 1992-01-23 JP JP4010094A patent/JPH05112595A/ja active Pending
- 1992-01-23 NZ NZ241381A patent/NZ241381A/en unknown
- 1992-01-23 MX MX9200294A patent/MX9200294A/es not_active IP Right Cessation
- 1992-01-23 EP EP92300580A patent/EP0496617B1/de not_active Expired - Lifetime
-
1993
- 1993-07-21 NO NO932628A patent/NO180418C/no unknown
- 1993-07-22 FI FI933303A patent/FI933303A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
IL100742A (en) | 1996-06-18 |
FI933303A0 (fi) | 1993-07-22 |
DE69230347T2 (de) | 2000-07-06 |
EP0496617A1 (de) | 1992-07-29 |
JPH05112595A (ja) | 1993-05-07 |
NO932628D0 (no) | 1993-07-21 |
FI933303A (fi) | 1993-08-31 |
MX9200294A (es) | 1993-01-01 |
EP0496617B1 (de) | 1999-12-01 |
NO180418B (no) | 1997-01-06 |
NZ241381A (en) | 1996-05-28 |
NO180418C (no) | 1997-04-16 |
NO932628L (no) | 1993-09-23 |
DE69230347D1 (de) | 2000-01-05 |
CA2100863A1 (en) | 1992-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE187175T1 (de) | Adenosinkinaseinhibitoren | |
DE69310178T2 (de) | K-252a DERIVATE | |
FI931708A0 (fi) | Herbicida substituerade aryl-haloalkylpyrazoler | |
DE3587500D1 (de) | Tumorbehandlung bei saeugetieren. | |
FI915920A0 (fi) | Serotoninantagonister. | |
DK0590428T3 (da) | Azaquinoxaliner, fremgangsmåde til deres fremstilling og deres anvendelse | |
SE8503680D0 (sv) | Indolderivat | |
BR9205811A (pt) | Derivados heterociclicos de aminas ciclicas | |
ATE264859T1 (de) | Neue adenosin-monophosphat-deaminase-inhibitoren | |
DE3887474D1 (de) | Verfahren zum Methylieren von 2,2,6,6-Tetramethylpiperidin enthaltenden Triazinverbindungen. | |
IN167848B (de) | ||
DE59109225D1 (de) | Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen | |
ES2042726T3 (es) | Beta-alquilmelatoninas. | |
DK0579968T3 (da) | 4-Iminoquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse | |
ATE187442T1 (de) | Tryptamine zur behandlung von störungen der circadianen rhythmik | |
ES2040750T3 (es) | Un procedimiento para la preparacion de un derivado de isoquinolinol. | |
DE58909244D1 (de) | Verwendung von 1,4-Dihydropyridin-Derivaten in der Behandlung von Alkoholsucht. | |
ES2046310T3 (es) | Mejoras en o relacionadas con inhibidores selectivos de absorcion de serotonina. | |
ATE87314T1 (de) | Platin-arzneimittel. | |
DE3767940D1 (de) | Pyranderivate. | |
ATE100462T1 (de) | 19-fluor- oder cyano-21-hydroxy-progesteronderivate als 19-hydroxylase-inhibitoren. | |
DK553587A (da) | Acylerede 9,10-anthracendicarboxaldehyd-bis-(2-imidazolin-2-ylhydrazoner), fremgangsmaade til deres fremstilling samt deres anvendelse | |
DE3864286D1 (de) | Herstellungsverfahren von trifluormethylverbindungen. | |
DE3682380D1 (de) | Stabilisiertes gossyplure und verfahren zu dessen herstellung. |